Pyridoxal 5′-phosphate-dependent
methionine γ-lyase
from Citrobacter freundii (MGL, EC
4.4.1.11) is studied as an antitumor enzyme and in combination with
substrates as an antibacterial agent in enzyme pro-drug therapy. For
the possibility of in vivo trials, two mutant forms,
C115H MGL and V358Y MGL, were encapsulated into polyionic vesicles
(PICsomes). Five pairs of polymers with the number of polymer chain
units 20, 50, 70, 120, and 160 were synthesized. The effect of polymer
lengthPEGylated poly-l-aspartic acid and poly-l-lysineon the degree of MGL incorporation into PICsomes
and their size was investigated. Encapsulation of proteins in PICsomes
is a rather new technique. Our data demonstrated that the length of
the polymers and, therefore, the ratio of the hydrophobic and hydrophilic
fragments most likely should be selected individually for each protein
to be encapsulated. The efficiency of encapsulation of MGL mutant
forms into PICsomes was up to 11%. The hydrodynamic diameter and surface
potential of hollow and MGL-loaded PICsomes were evaluated by the
dynamic light scattering method. The size and morphology of the PICsomes
were determined by atomic force microscopy. The most acceptable for
further in vivo studies were PICsomes20 with a size of 57–64 nm, PICsomes70 of 50–90
nm, and PICsomes120 of 100–105 nm. The analysis
of the steady-state parameters has demonstrated that both mutant forms
retained their catalytic properties inside the nanoparticles. The
release study of the enzymes from PICsomes revealed that about 50%
of the enzymes remained encapsulated in PICsomes70 and
PICsomes120 after 24 h. Based on the data obtained, the
most promising for in vivo studies are PICsomes70 and PICsomes120.